Report Detail

Other Global Narcolepsy Therapeutics Market Size, Status and Forecast 2019-2025

  • RnM3472174
  • |
  • 12 July, 2019
  • |
  • Global
  • |
  • 97 Pages
  • |
  • QYResearch
  • |
  • Other

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Narcolepsy Therapeutics Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Central nervous system stimulants
      • 1.4.3 Sodium Oxybate
      • 1.4.4 Selective Serotonin Reuptake Inhibitor (SSRI)
      • 1.4.5 Tricyclic Antidepressants
      • 1.4.6 Others
    • 1.5 Market by Application
      • 1.5.1 Global Narcolepsy Therapeutics Market Share by Application (2014-2025)
      • 1.5.2 Narcolepsy With Cataplexy
      • 1.5.3 Narcolepsy Without Cataplexy
      • 1.5.4 Secondary Narcolepsy
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Narcolepsy Therapeutics Market Size
    • 2.2 Narcolepsy Therapeutics Growth Trends by Regions
      • 2.2.1 Narcolepsy Therapeutics Market Size by Regions (2014-2025)
      • 2.2.2 Narcolepsy Therapeutics Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Narcolepsy Therapeutics Market Size by Manufacturers
      • 3.1.1 Global Narcolepsy Therapeutics Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Narcolepsy Therapeutics Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Narcolepsy Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.2 Narcolepsy Therapeutics Key Players Head office and Area Served
    • 3.3 Key Players Narcolepsy Therapeutics Product/Solution/Service
    • 3.4 Date of Enter into Narcolepsy Therapeutics Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Narcolepsy Therapeutics Market Size by Type (2014-2019)
    • 4.2 Global Narcolepsy Therapeutics Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Narcolepsy Therapeutics Market Size (2014-2019)
    • 5.2 Narcolepsy Therapeutics Key Players in United States
    • 5.3 United States Narcolepsy Therapeutics Market Size by Type
    • 5.4 United States Narcolepsy Therapeutics Market Size by Application

    6 Europe

    • 6.1 Europe Narcolepsy Therapeutics Market Size (2014-2019)
    • 6.2 Narcolepsy Therapeutics Key Players in Europe
    • 6.3 Europe Narcolepsy Therapeutics Market Size by Type
    • 6.4 Europe Narcolepsy Therapeutics Market Size by Application

    7 China

    • 7.1 China Narcolepsy Therapeutics Market Size (2014-2019)
    • 7.2 Narcolepsy Therapeutics Key Players in China
    • 7.3 China Narcolepsy Therapeutics Market Size by Type
    • 7.4 China Narcolepsy Therapeutics Market Size by Application

    8 Japan

    • 8.1 Japan Narcolepsy Therapeutics Market Size (2014-2019)
    • 8.2 Narcolepsy Therapeutics Key Players in Japan
    • 8.3 Japan Narcolepsy Therapeutics Market Size by Type
    • 8.4 Japan Narcolepsy Therapeutics Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Narcolepsy Therapeutics Market Size (2014-2019)
    • 9.2 Narcolepsy Therapeutics Key Players in Southeast Asia
    • 9.3 Southeast Asia Narcolepsy Therapeutics Market Size by Type
    • 9.4 Southeast Asia Narcolepsy Therapeutics Market Size by Application

    10 India

    • 10.1 India Narcolepsy Therapeutics Market Size (2014-2019)
    • 10.2 Narcolepsy Therapeutics Key Players in India
    • 10.3 India Narcolepsy Therapeutics Market Size by Type
    • 10.4 India Narcolepsy Therapeutics Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Narcolepsy Therapeutics Market Size (2014-2019)
    • 11.2 Narcolepsy Therapeutics Key Players in Central & South America
    • 11.3 Central & South America Narcolepsy Therapeutics Market Size by Type
    • 11.4 Central & South America Narcolepsy Therapeutics Market Size by Application

    12 International Players Profiles

    • 12.1 Addrenex Pharmaceuticals, Inc.
      • 12.1.1 Addrenex Pharmaceuticals, Inc. Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Narcolepsy Therapeutics Introduction
      • 12.1.4 Addrenex Pharmaceuticals, Inc. Revenue in Narcolepsy Therapeutics Business (2014-2019)
      • 12.1.5 Addrenex Pharmaceuticals, Inc. Recent Development
    • 12.2 Teva Pharmaceutical Industries Ltd.
      • 12.2.1 Teva Pharmaceutical Industries Ltd. Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Narcolepsy Therapeutics Introduction
      • 12.2.4 Teva Pharmaceutical Industries Ltd. Revenue in Narcolepsy Therapeutics Business (2014-2019)
      • 12.2.5 Teva Pharmaceutical Industries Ltd. Recent Development
    • 12.3 Jazz Pharmaceuticals PLC
      • 12.3.1 Jazz Pharmaceuticals PLC Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Narcolepsy Therapeutics Introduction
      • 12.3.4 Jazz Pharmaceuticals PLC Revenue in Narcolepsy Therapeutics Business (2014-2019)
      • 12.3.5 Jazz Pharmaceuticals PLC Recent Development
    • 12.4 Graymark Healthcare, Inc.
      • 12.4.1 Graymark Healthcare, Inc. Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Narcolepsy Therapeutics Introduction
      • 12.4.4 Graymark Healthcare, Inc. Revenue in Narcolepsy Therapeutics Business (2014-2019)
      • 12.4.5 Graymark Healthcare, Inc. Recent Development
    • 12.5 Arena Pharmaceuticals, Inc.
      • 12.5.1 Arena Pharmaceuticals, Inc. Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Narcolepsy Therapeutics Introduction
      • 12.5.4 Arena Pharmaceuticals, Inc. Revenue in Narcolepsy Therapeutics Business (2014-2019)
      • 12.5.5 Arena Pharmaceuticals, Inc. Recent Development
    • 12.6 BIOPROJET
      • 12.6.1 BIOPROJET Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Narcolepsy Therapeutics Introduction
      • 12.6.4 BIOPROJET Revenue in Narcolepsy Therapeutics Business (2014-2019)
      • 12.6.5 BIOPROJET Recent Development
    • 12.7 Shire
      • 12.7.1 Shire Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Narcolepsy Therapeutics Introduction
      • 12.7.4 Shire Revenue in Narcolepsy Therapeutics Business (2014-2019)
      • 12.7.5 Shire Recent Development
    • 12.8 Ligand Pharmaceuticals, Inc.
      • 12.8.1 Ligand Pharmaceuticals, Inc. Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Narcolepsy Therapeutics Introduction
      • 12.8.4 Ligand Pharmaceuticals, Inc. Revenue in Narcolepsy Therapeutics Business (2014-2019)
      • 12.8.5 Ligand Pharmaceuticals, Inc. Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Narcolepsy is a chronic neurological disorder and results from the inability of one s body to regulate sleep-wake cycles. ... These sleep periods can range from seconds or minutes and in most extreme cases sometimes hours at one time.
      In 2018, the global Narcolepsy Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Narcolepsy Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Narcolepsy Therapeutics development in United States, Europe and China.

      The key players covered in this study
      Addrenex Pharmaceuticals, Inc.
      Teva Pharmaceutical Industries Ltd.
      Jazz Pharmaceuticals PLC
      Graymark Healthcare, Inc.
      Arena Pharmaceuticals, Inc.
      BIOPROJET
      Shire
      Ligand Pharmaceuticals, Inc.

      Market segment by Type, the product can be split into
      Central nervous system stimulants
      Sodium Oxybate
      Selective Serotonin Reuptake Inhibitor (SSRI)
      Tricyclic Antidepressants
      Others

      Market segment by Application, split into
      Narcolepsy With Cataplexy
      Narcolepsy Without Cataplexy
      Secondary Narcolepsy

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Narcolepsy Therapeutics status, future forecast, growth opportunity, key market and key players.
      To present the Narcolepsy Therapeutics development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Narcolepsy Therapeutics are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Narcolepsy Therapeutics. Industry analysis & Market Report on Narcolepsy Therapeutics is a syndicated market report, published as Global Narcolepsy Therapeutics Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Narcolepsy Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,052.87
      4,579.30
      6,105.73
      3,531.07
      5,296.61
      7,062.14
      424,164.00
      636,246.00
      848,328.00
      278,733.39
      418,100.09
      557,466.78
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report